PATENTSCOPE will be unavailable a few hours for maintenance reason on Monday 03.02.2020 at 10:00 AM CET
Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (WO2020006115) METHODS OF TREATING CANCER USING A CLK INHIBITOR
Latest bibliographic data on file with the International BureauSubmit observation

Pub. No.: WO/2020/006115 International Application No.: PCT/US2019/039301
Publication Date: 02.01.2020 International Filing Date: 26.06.2019
IPC:
A61K 31/41 (2006.01) ,A61K 31/415 (2006.01) ,A61K 31/437 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
41
having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
41
having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole
415
1,2-Diazoles
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
435
having six-membered rings with one nitrogen as the only ring hetero atom
4353
ortho- or peri-condensed with heterocyclic ring systems
437
the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
Applicants:
TAM, Betty [US/US]; US
BOSSARD, Carine [US/US]; US
CHIU, Kevin Tseng [US/US]; US
CHUNG, Heekyung [US/US]; US
DELLAMARY, Luis A. [US/US]; US
MAK, Chi Ching [US/US]; US
DO, Long Hoang [US/US]; US
CHO, Seong Yeon [US/US]; US
JERVIS, Luke [US/US]; US
Inventors:
TAM, Betty; US
BOSSARD, Carine; US
CHIU, Kevin Tseng; US
CHUNG, Heekyung; US
DELLAMARY, Luis A.; US
MAK, Chi Ching; US
DO, Long Hoang; US
CHO, Seong Yeon; US
JERVIS, Luke; US
Agent:
REITER, Tiffany; US
LAVOIE, Teresa A.; US
Priority Data:
62/690,14626.06.2018US
62/846,33510.05.2019US
Title (EN) METHODS OF TREATING CANCER USING A CLK INHIBITOR
(FR) MÉTHODES DE TRAITEMENT DU CANCER À L'AIDE D'UN INHIBITEUR DE CLK
Abstract:
(EN) Provided herein are methods of treating a cancer in a subject using a CLK inhibitor or pharmaceutically acceptable salt or solvate thereof.
(FR) L'invention concerne des méthodes de traitement d'un cancer chez un sujet à l'aide d'un inhibiteur de CLK ou d'un sel ou d'un solvate pharmaceutiquement acceptable de celui-ci.
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)